FDA committee recommends stronger warnings against inappropriate use of immediate-release nifedipine.
Miller
J L
JL
D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D002121:Calcium Channel Blockers; D009543:Nifedipine